Regarding HPV vaccine: 1) Reduction recommended dosages for girls from 3 to 1. 2) Include boys in the HPV vaccination program and adjust promotion material/campaign. 3) Monitoring of effect of implementation; before and after promotion. 4) Evaluate costs vaccination and adjust vaccine orders (based on coverage among other variables).
Regarding other topics: 1) Extended expiration date Pfizer; extended expiration date provided by manufacturer to be evaluated by national pharmaceutical inspection board. 2) Implementation NMAT next meeting; NMAT presentation to be mailed prior to next meeting. 3) Virtual participation in the GNN; different sections to be covered by different NITAG members.